The only FDA approved manufacturer of anthrax vaccines in the world, Michigan-based BioPort, will help the Department of Defense step up its distribution of the vaccine.
The Department of Defense announced Friday it would supply anthrax vaccines to military personnel who may be deployed to a "high threat" area for more than 15 days. Members of the military will start taking the vaccine somewhere around 45 days before they are deployed to the "high threat" area.
The Department of Defense may also resume distribution of the vaccine to civilians who are at high risk of coming in contact with anthrax including lab workers and emergency workers.
Bob Kramer, president of BioPort, said BioPort is ready to accommodate the government's need for vaccines, and it will work with various agencies to develop an expansion plan that will best supply the vaccine wherever it is needed.